CannabisNewsBreaks

ThursdayMay 12, 2022 2:10 pm

CannabisNewsBreaks – Alternative Products Expo to Shine the Spotlight on Innovative Products, Services Disrupting Traditional Markets

Following numerous successful events in North America, the Alternative Products Expo is set to take place on May 21-22 at Plaza Mayor in Medellin, Colombia. Alternative Products Expo Colombia will feature 50-plus expert speakers, over 125 exhibitors and more than 1,000 of the most innovative and cutting-edge products within the alternative products space. Through keynotes, panels and workshops, industry experts will share their insights and educate attendees about the latest trends in the alternative products ecosystem. The one-of-a-kind business networking event will showcase all categories of innovative products and services currently disrupting traditional markets. The alternative products category typically includes…

Continue Reading

ThursdayMay 12, 2022 11:43 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Global Footprint to Establish Presence in the UK and EU

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced expansion of its operational footprint in Europe and the United Kingdom, furthering its international growth strategy. According to the update, the London-based offices will serve as the regional headquarters for Flora’s sales force and management of its distribution centers in the U.K. and Netherlands. Flora additionally bolsters its strategic positioning in the region by partnering with Hoshi to distribute the company’s broader product portfolio to 11 countries, including Germany, Portugal, the U.K., Italy, Poland, the Czech Republic, Denmark, the Netherlands, Switzerland, Malta,…

Continue Reading

WednesdayMay 11, 2022 3:22 pm

CannabisNewsBreaks – CWCBExpo New York’s ‘In Conversation With’ Series to Feature Prolific Industry Leaders

Two prolific leaders in the cannabis and hemp industry, Chris Beals and Nick Kovacevich, will be featured speakers in the “In Conversation with…” series at CWCBExpo New York. The event is slated to take place June 2-4 at the Javits Center. The East Coast’s top B2B trade show and conference, CWCBExpo brings together some of the most influential and informed minds in the industry to discuss the latest in the areas of adult use legalization and legislation and its impact on businesses, communities and lifestyle. “I am thrilled to sit down with Mona at this year’s CWCBExpo New York to…

Continue Reading

WednesdayMay 11, 2022 2:06 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Launch of Vessel in Canada, OCS Partnership

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its Vessel brand, a leader in premium cannabis accessories, secured meaningful penetration in Canada via an approved listing on the Ontario Cannabis Store (“OCS”). In addition, Vessel has launched its Canadian direct-to-consumer online store, www.VesselBrand.ca, to service customers directly across the country. “We’re elated about our partnership with the OCS and are looking forward to bringing the full Vessel experience to our loyal customers across Canada,” said Flora’s Chief Strategy Officer James Choe. “Our internal estimates show the Canadian cannabis market…

Continue Reading

WednesdayMay 11, 2022 1:19 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding Reach, Reports ‘Significant Balance Sheet and Operational Improvements’

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) has been strengthening its revenue streams in the states where it operates, particularly in Michigan, Florida and California of late, while also working to deal with its debt to make it more long-term feasible, announcing recently that it has eliminated several million dollars’ worth of liabilities and annual expenses. “The acquisition earlier this year of a 15,000-square-foot manufacturing, processing and distribution facility as well as properties owned by PharmaCo Inc., in Michigan, plus full licensing for manufacturing both medical and adult-use cannabis products in the state, assured RWB’s efforts to become fully…

Continue Reading

TuesdayMay 10, 2022 3:02 pm

CannabisNewsBreaks – BizCann Expo Colombia to Showcase Latest Trends in Cannabusiness

The BizCann Expo, an elite business and networking event for everything cannabis, today announced details for its upcoming event at the Plaza Mayor in Medellin, Colombia, on May 21-22. For established cannabusiness providers or those looking for entry into this new, rapidly expanding market, BizCann Expo has everything needed to start or scale a canna-venture or to service the cannabusiness sector. BizCann Expo Colombia and Alternative Products Expo are co-located in the cannabis gateway to South America. Through a surprisingly robust legislative framework, Medellin is hosting the event that will bridge the North American and South American markets and jumpstart…

Continue Reading

TuesdayMay 10, 2022 2:41 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces FY 2021 Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today released its financial and operating results for the fiscal year ended Dec. 31, 2021. “Fiscal year 2021 was a foundational year for our company as we closed our first full year of revenues. In 2022, we anticipate accelerating revenue growth as we activate our Wholesale and Life Sciences growth pillars, while fueling expansion in our global House of Brands,” said Luis Merchan, chairman and CEO of Flora. “We are proud of the milestones we achieved in 2021, including the completion of key strategic…

Continue Reading

MondayMay 09, 2022 2:17 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of which are not yet available in commercial-size quantities, such as cannabidivarin – (“CBDV”) and tetrahydrocannabivarin – (“THCV”). “The acquisition of BayMedica in October 2021 has provided an advantage for InMed in the rare cannabinoid biosynthesis industry,” reads a recent article discussing the company. “BayMedica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector and…

Continue Reading

MondayMay 09, 2022 1:11 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Update on Proposed Acquisition of Diagnostic Lab Corporation

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, today issued an update on its previously announced execution of a memorandum of understanding (“MOU”) with Englewood Cliffs, New Jersey-based Diagnostic Lab Corporation (“DLC”), a diversified food and agriculture safety company, concerning Grapefruit’s acquisition of DLC. According to the update, the company and DLC (the “parties”) have been in regular discussions since the execution of the MOU regarding the terms and timing of the proposed acquisition. The parties have developed a plan, under which Grapefruit will acquire substantially all of the assets of DLC and obtain financing of $12.5 million, $7…

Continue Reading

FridayMay 06, 2022 3:13 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-Nicotine Pouch Performance to Be Compared to That of Leading Brands

Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands available to U.S. customers, namely ON! and Zyn,” a recent article reads. The human study NIC-H22-1 is expected to build on the successes of the company’s animal studies, which have proven the technology’s effectiveness in promoting faster absorption, higher peak absorption, and greater overall quantities of nicotine, on average, in the blood than concentration-matched control formulations. “In 2021, the company…

Continue Reading